These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12635570)

  • 1. Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment.
    Spivak M; Adams B; Crockford D
    Can J Psychiatry; 2003 Feb; 48(1):66. PubMed ID: 12635570
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome with antidepressant/antipsychotic drug combination.
    Garcia G; Ghani S; Poveda RA; Dansky BL
    Ann Pharmacother; 2001 Jun; 35(6):784-5. PubMed ID: 11409001
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome: an experience of four cases.
    Desai ND; Mundra VK; Gore YS; Diwan PJ; Jaydeokar SS; Jain V; Sutharsan R; Agarwal A; Moulick ND; Manocha SM
    J Assoc Physicians India; 1998 Jul; 46(7):653-4. PubMed ID: 12152854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 11. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.
    Stoudemire A; Clayton L
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):303-5. PubMed ID: 2577714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
    Crosby D; Peterson J; Carroll BT
    Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics].
    Chitaia NN; Danilov DS; Tiuvina NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):37-43. PubMed ID: 19365390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
    Amador EC; Kassam A; Hopp C; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
    Tadke RR; Suryavanshi P
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):131-2. PubMed ID: 16525085
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
    Ravanic DB; Dejanovic SM; Janjic V; Jovic SD; Milovanovic DR; Jakovljevic V; Pantovic V; Ravanic B; Pantovic M; Pantovic MM
    Arq Neuropsiquiatr; 2009 Jun; 67(2A):195-202. PubMed ID: 19547808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Catatonic dilemma". Therapy with lorazepam and clozapine].
    Lausberg H; Hellweg R
    Nervenarzt; 1998 Sep; 69(9):818-22. PubMed ID: 9789276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.